Mapping the protein surface of human immunodeficiency virus type 1 gp120 using human monoclonal antibodies from phage display libraries

Journal of Molecular Biology

Volumn 267, Issue 3, 1997, Pages 684-695

  Ditzel, Henrik J ^a,b,c   Parren, Paul W H I ^a   Binley, James M ^a,d   Sodroski, Joseph ^e   Moore, John P ^d   Barbas III, Carlos F ^a   Burton, Dennis R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c Rigshospitalet   (Denmark)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Combinatorial libraries; Epitope mapping; gp120 topology; HIV infection; Human antibody repertoires

Indexed keywords

GLYCOPROTEIN GP 120; HUMAN MONOCLONAL ANTIBODY; IMMUNOGLOBULIN F(AB) FRAGMENT; RECOMBINANT PROTEIN; VIRUS PROTEIN;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CRYSTAL STRUCTURE; EPITOPE MAPPING; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNIZATION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN STRUCTURE;

EID: 0031552347     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1997.0912     Document Type: Article

References (45)

1. Barbas C. F., Kang A. S., Lerner R. A., Benkovic S. J. Assembly of combinatorial antibody libraries on phage surfaces: the gene III site. Proc. Natl Acad. Sci. USA. 88:1991;7978-7982.
2. Barbas C. F., Bjorling E., Chiodi F., Dunlop N., Cababa D., Jones T. M., Zebedee S. L., Persson M. A., Nara P. L., Norrby E., Burton D. R. Recombinant human Fab fragments neutralize human type 1 immunodeficiency virus in vitro. Proc. Natl Acad. Sci. USA. 89:1992;9339-9343.
3. Barbas C. F., Collet T. A., Amberg W., Roben P., Binley J. M., Hoekstra D., Cababa D., Jones T. M., Williamson R. A., Pilkington G. R., Haigwood N. L., Cabezas E., Satterthwait A. C., Sanz I., Burton D. R. Molecular profile of an antibody response to HIV-1 as probed by combinatorial libraries. J. Mol. Biol. 230:1993;812-823.
4. Binley J. M., Ditzel H. J., Barbas C. F., Sullivan N., Sodroski J., Parren P. W. H. I., Burton D. R. Human antibody responses to HIV-1 gp41 cloned in phage display libraries suggest three major epitopes are recognized and give evidence for conserved antibody motifs in antigen binding. AIDS Res. Hum. Retrovir. 12:1996;911-924.
5. Burton D. R., Barbas C. F. Human antibodies from combinatorial libraries. Advan. Immunol. 57:1994;191-280.
6. Burton D. R., Barbas C. F., Persson M. A., Koenig S., Chanock R. M., Lerner R. A. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc. Natl Acad. Sci. USA. 88:1991;10134-10137.
7. Burton D. R., Montefiori D. C. The antibody response in HIV-1 infection. AIDS. 1997.
8. Burton D. R., Pyati J., Koduri R., Sharp S. J., Thornton G. B., Parren P. W. H. I., Sawyer L. S. W., Hendry R. M., Dunlop N., Nara P. L., Lamacchia M., Garratty E., Stiehm E. R., Bryson Y. J., Cao Y., Moore J. P., Ho D. D., Barbas C. F. Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody. Science. 266:1994;1024-1027.
9. di Marzo Veronese F. R., Rahman R., Pal R., Boyer C., Romano J., Kalyanaraman V. S., Nair B. C., Gallo R. C., Sarngadharan M. G. Delineation of immunoreactive, conserved regions in the external envelope glycoprotein of the human immunodeficiency virus type I. AIDS Res. Hum. Retrovir. 8:1992;1125-1132.
10. Ditzel H. J., Barbas S. M., Barbas C. F., Burton D. R. The nature of the autoimmune antibody repertoire in human immunodeficiency virus type 1 infection. Proc. Natl Acad. Sci. USA. 91:1994;3710-3714.
11. Ditzel H. J., Binley J. M., Moore J. P., Sodroski J., Sullivan N., Sawyer L. S. W., Hendry R. M., Yang W.-P., Barbas C. F., Burton D. R. Neutralizing recombinant human antibodies to a conformational V2- and CD4-binding site-sensitive epitope of HIV-1 gp120 isolated by using an epitope-masking procedure. J. Immunol. 154:1995;895-908.
12. Earl P. L., Broder C. C., Long D., Lee S. A., Peterson J., Chakrabarti S., Doms R. W., Moss B. Native oligomeric human immunodeficiency virus type 1 envelope glycoprotein elicits diverse monoclonal antibody reactivities. J. Virol. 68:1994;3015-3026.
13. Fung M. S. C., Sun C. R. Y., Gordon W. L., Liou R.-S., Chang T. W., Sun W. N. C., Daar E. S., Ho D. D. Identification and characterization of a neutralization site within the second variable region of human immunodeficiency virus type 1 gp120. J. Virol. 66:1992;848-840.
14. Gallaher W. R., Ball J. M., Garry R. F., Martin-Amedee A., Montelaro R. C. A general model for the surface glycoproteins of HIV and other retroviruses. AIDS Res. Hum. Retrovir. 11:1995;191-202.
15. Hanson C. V., Crawford-Miksza L., Sheppard H. W. Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers. J. Clin. Microbiol. 28:1990;2030-2034.
16. Helseth E., Kowalski M., Gabuzda D., Olshevsky U., Haseltine W., Sodroski J. Rapid complementation assays measuring replicative potential of human immunodeficiency virus type 1 envelope glycoprotein mutants. J. Virol. 64:1990;2416-2420.
17. Ho D. D., Fung M. S. C., Cao Y. Z., Li X. L., Sun C., Chang T. W., Sun N. C. Another discontinuous epitope on glycoprotein gp120 that is important in human immunodeficiency virus type 1 neutralization is identified by a monoclonal antibody. Proc. Natl Acad. Sci. USA. 88:1991;8949-8952.
18. Ho D. D., Neumann A. U., Perelson A. S., Chen W., Leonard J. M., Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature. 373:1995;123-126.
19. Kang C.-Y., Hariharan K., Nara P. L., Sodroski J., Moore J. P. Immunization with a soluble CD4-gp120 complex preferentially induces neutralizing anti-human immunodeficiency virus type 1 antibodies directed to conformation-dependent epitopes of gp120. J. Virol. 68:1994;5854-5862.
20. Karlsson R. A., Michaelsson A., Mattsson L. Kinetic analysis of monoclonal antibody-antigen interactions with a new biosensor based analytical system. J. Immunol. Methods. 145:1991;229-240.
21. Kayman S. C., Wu Z., Revesz K., Chen H., Kopelman R., Pinter A. Presentation of native epitopes in the V1/V2 and V3 regions of human immunodeficiency virus type 1 gp120 by fusion glycoproteins containing isolated gp120 domains. J. Virol. 68:1994;400-410.
22. Laman J. D., Schellekens M. M., Abacioglu Y. F., Lewis G. K., Tersmette M., Fouchier R. A. M., Langedijk J. P. M., Claassen E., Boersma W. J. A. Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from gp120 third variable domain. J. Virol. 66:1992;1823-1831.
23. Modrow S., Hahn B. H., Shaw G. M., Gallo R. C., Wong-Staal F., Wolf H. Computer-assisted analysis of envelope protein sequences of seven human immunodeficiency virus isolates: prediction of antigenic epitopes in conserved and variable regions. J. Virol. 61:1987;570-578.
24. Moore J. P., Ho D. D. Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J. Virol. 67:1993;863-875.
25. Moore J. P., Ho D. D. HIV-1 neutralization: the consequences of viral adaptation to growth on transformed T cells. AIDS. 9(suppl A):1995;S117-S136.
26. Moore J. P., Sodroski J. Antibody cross-competition analysis of the human immundeficiency virus type 1 gp120 exterior envelope glycoprotein. J. Virol. 70:1996;1863-1872.
27. Moore J. P., Sattentau Q. J., Yoshiyama H., Thali M., Charles M., Sullivan N., Poon S.-W., Fung M. S., Traincard F., Pinkus M., Robey G., Robinson J. E., Ho D. D., Sodroski J. Probing the structure of the V2 domain of human immunodeficiency virus type 1 surface glycoprotein gp120 with a panel of eight monoclonal antibodies: human immune response to the V1 and V2 domains. J. Virol. 67:1993a;6136-6151.
28. Moore J. P., Thali M., Jameson B. A., Vignaux F., Lewis G. K., Poon S.-W., Charles M., Fung M. S., Sun B., Durda P. J., Akerblom L., Wahren B., Ho D. D., Sattentau Q. J., Sodroski J. Immunochemical analysis of the gp120 surface glycoprotein of human immunodeficiency virus type 1: probing the structure of the C4 and V4 domains and the interaction of the C4 domain with the V3 loop. J. Virol. 67:1993b;4785-4796.
29. Moore J. P., Sattentau Q. J., Wyatt R., Sodroski J. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:1994a;469-484.
30. Moore J. P., Willey R. L., Lewis G. K., Robinson J., Sodroski J. Immunological evidence for interactions between the first, second, and fifth conserved domains of the gp120 surface glycoprotein of human immunodeficiency virus type 1. J. Virol. 68:1994b;6836-6847.
31. Moore J. P., Cao Y., Qing L., Sattentau Q. J., Pyati J., Koduri R., Robinson J., Barbas C. F., Burton D. R., Ho D. D. Primary isolates of human immunodeficiency virus type 1 are relatively resistant to neutralization by monoclonal antibodies to gp120, and their neutralization is not predicted by studies with monomeric gp120. J. Virol. 69:1995;101-109.
32. Nara P. L., Hatch W. C., Dunlop N. M., Robey W. G., Arthur L. O., Gonda M. A., Fischinger P. J. Simple, rapid, quantitative syncytium-forming microassay for the detection of human immunodeficiency virus neutralizing antibody. AIDS Res. Hum. Retrovir. 3:1987;283-302.
33. Parren P. W. H. I., Fisicaro P., Labrijn A. F., Binley J. M., Yang W. P., Ditzel H. J., Barbas C. F., Burton D. R. In vitro antigen challenge of human antibody libraries for vaccine evaluation: the human immunodeficiency virus type I envelope. J. Virol. 70:1996;9046-9050.
34. Persson M. A., Caothien R. H., Burton D. R. Generation of diverse high-affinity human monoclonal antibodies by repertoire cloning. Proc. Natl Acad. Sci. USA. 88:1991;2432-2436.
35. Poignard P., Klasse P.-J., Sattentau Q. J. Antibody neutralization of HIV-1. Immunol. Today. 17:1996;239-246.
36. Roben P., Moore J. P., Thali M., Sodroski J., Barbas C. F., Burton D. R. Recognition properties of a panel of human recombinant Fab fragments to the CD4 binding site of gp120 that show differing abilities to neutralize human immunodeficiency virus type 1. J. Virol. 68:1994;4821-4828.
37. Sattentau Q. J., Moore J. P. Human immunodeficiency virus type 1 neutralization is determined by epitope exposure on the gp120 oligomer. J. Exp. Med. 182:1995;185-196.
38. Sodroski J., Wyatt R., Olshevsky U., Olshevsky V., Moore J. Conformation of the HIV-1 gp120 envelope glycoprotein. Development and Applications of Vaccines and Gene Therapy in AIDS, Antibiot Chemother. 1996;Karger, Basel.
39. Starcich B. R., Hahn B. H., Shaw G. M., McNeal P. D., Modrow, Wolf H., Parks W. P., Josephs F., Gallo R. C., Wong-Staal F. Identification and characterization of conserved and variable regions in the envelope gene of HTLVIII/LAV the retrovirus of AIDS. Cell. 45:1986;637-648.
40. Sullivan N., Thali M., Furman C., Ho D. D., Sodroski J. Effect of amino acid changes in the V1/V2 region of the human immunodeficiency virus type 1 gp120 glycoprotein on subunit association, syncytium formation, and recognition by a neutralizing antibody. J. Virol. 67:1993;3674-3679.
41. Thali M., Moore J. P., Furman C., Charles M., Ho D. D., Robinson J., Sodroski J. Characterization of conserved human immunodeficiency virus type 1 gp120 neutralization epitopes exposed upon gp120-CD4 binding. J. Virol. 67:1993;3978-3988.
42. Trkola A., Pomales A. P., Yuan H., Korber B., Maddon P. J., Allaway G., Katinger H., Barbas C. F., Burton D. R., Ho D. D., Moore J. P. Cross-clade neutralization of primary isolates of human immunodeficiency virus type 1 by human monoclonal antibodies and tetrameric CD4-IgG. J. Virol. 69:1995;6609-6617.
43. Wei X., Ghosh S. K., Taylor M. E., Johnson V. A., Emini E. A., Deutsch P., Lifson J. D., Bonhoeffer S., Nowak M. A., Hahn B. H., Saag M. S., Shaw G. M. Viral dynamics in human immunodeficiency virus type 1 infection. Nature. 373:1995;117-122.
44. Winter G., Griffiths A. D., Hawkins R. E., Hoogenboom H. R. Making antibodies by phage display technology. Annu. Rev. Immunol. 12:1994;433-455.
45. Wyatt R., Thali M., Tilley S., Pinter A., Posner M., Ho D., Robinson J., Sodroski J. Relationship of the human immunodeficiency virus type 1 gp120 third variable loop to a component of the CD4 binding site in the fourth conserved region. J. Virol. 66:1992;6997-7004.